In conclusion, this study uncovers a role of the DNAJA2-CMA axis in maintaining genome stability in human cells and provides strategies to advance the HSPs-based cancer therapy by targeting HSP40s in cancer immunotherapy. This evidence concerns the gene DNAJA2 and cancer.